Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › P3 peptidylic inhibitors for treating CAG-repeat RNA toxicity in polyglutamine diseases

P3 peptidylic inhibitors for treating CAG-repeat RNA toxicity in polyglutamine diseases

US Patent 10570177 · Granted Feb 25, 2020

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Performing data pre-processing operations during data preparation of a machine l2025
Noisy transaction for protection of data2025
Secret smart operations in blockchain2025
Clonal strains of attenuated vaccinia viruses and methods of use thereof2025
Nucleic acid molecules encoding bispecific anti-BCMA x anti-CD3 antibodies2025
System and method for predicting susceptibility of genus Klebsiella to amikacin2024
Phytase variants and polynucleotides encoding same2024
Bacillus velezensis, culture method therefor and application thereof2024
Wearable three-dimensional auricular multi-point bio-signal acquisition, health 2024
Peptidylic inhibitors of nucleolin (NCL) targeting CAG-repeat RNA toxicity and m2023
Peptidylic inhibitors of nucleolin (NCL) targeting CAG-repeat RNA toxicity and m2023
Peptidylic inhibitors of nucleolin (NCL) targeting CAG-repeat RNA toxicity and m2023